Volgen
Suresh Palaniyandi
Suresh Palaniyandi
Senior Staff Investigator, Henry Ford Health System
Geverifieerd e-mailadres voor hfhs.org
Titel
Geciteerd door
Geciteerd door
Jaar
Protein kinase C in heart failure: a therapeutic target?
SS Palaniyandi, L Sun, JCB Ferreira, D Mochly-Rosen
Cardiovascular research 82 (2), 229-239, 2009
2352009
14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy
RA Thandavarayan, K Watanabe, M Ma, PT Veeraveedu, N Gurusamy, ...
Biochemical pharmacology 75 (9), 1797-1806, 2008
1162008
Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease
VR Mali, SS Palaniyandi
Free radical research 48 (3), 251-263, 2014
1092014
Modulation of AT-1R/CHOP-JNK-Caspase12 pathway by olmesartan treatment attenuates ER stress-induced renal apoptosis in streptozotocin-induced diabetic mice
AP Lakshmanan, RA Thandavarayan, SS Palaniyandi, FR Sari, H Meilei, ...
European journal of pharmaceutical sciences 44 (5), 627-634, 2011
992011
Comparative effects of torasemide and furosemide in rats with heart failure
PT Veeraveedu, K Watanabe, M Ma, RA Thandavarayan, SS Palaniyandi, ...
Biochemical pharmacology 75 (3), 649-659, 2008
872008
Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy
PT Veeraveedu, K Watanabe, M Ma, SS Palaniyandi, K Yamaguchi, ...
European journal of pharmacology 581 (1-2), 121-131, 2008
742008
Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats
M Soga, FA Kamal, K Watanabe, M Ma, S Palaniyandi, P Prakash, ...
International journal of cardiology 110 (3), 378-385, 2006
732006
Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin
VR Mali, R Ning, J Chen, XP Yang, J Xu, SS Palaniyandi
Experimental Biology and Medicine 239 (5), 610-618, 2014
722014
Regulation of mitochondrial processes: a target for heart failure
SS Palaniyandi, X Qi, G Yogalingam, JCB Ferreira, D Mochly-Rosen
Drug Discovery Today: Disease Mechanisms 7 (2), e95-e102, 2010
722010
Modulation of macrophage polarization and HMGB1-TLR2/TLR4 cascade plays a crucial role for cardiac remodeling in senescence-accelerated prone mice
V Karuppagounder, VV Giridharan, S Arumugam, R Sreedhar, ...
PloS one 11 (4), e0152922, 2016
702016
Quercetin offers cardioprotection against progression of experimental autoimmune myocarditis by suppression of oxidative and endoplasmic reticulum stress via endothelin-1/MAPK …
S Arumugam, RA Thandavarayan, W Arozal, FR Sari, VV Giridharan, ...
Free radical research 46 (2), 154-163, 2012
702012
Depletion of 14-3-3 protein exacerbates cardiac oxidative stress, inflammation and remodeling process via modulation of MAPK/NF-ĸB signaling pathways after streptozotocin …
RA Thandavarayan, VV Giridharan, FR Sari, S Arumugam, ...
Cellular Physiology and Biochemistry 28 (5), 911-922, 2011
692011
Inhibition of mast cells by interleukin‐10 gene transfer contributes to protection against acute myocarditis in rats
SS Palaniyandi, K Watanabe, M Ma, H Tachikawa, M Kodama, Y Aizawa
European journal of immunology 34 (12), 3508-3515, 2004
612004
Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats
SS Palaniyandi, Y Nagai, K Watanabe, M Ma, PT Veeraveedu, P Prakash, ...
Experimental Biology and Medicine 232 (9), 1213-1221, 2007
572007
Tiny molecule, big power: multi-target approach for curcumin in diabetic cardiomyopathy
V Karuppagounder, S Arumugam, VV Giridharan, R Sreedhar, RJC Bose, ...
Nutrition 34, 47-54, 2017
542017
Mast cells and ɛPKC: A role in cardiac remodeling in hypertension-induced heart failure
SS Palaniyandi, K Inagaki, D Mochly-Rosen
Journal of molecular and cellular cardiology 45 (6), 779-786, 2008
502008
Blockade of interferon‐γ‐inducible protein‐10 attenuates chronic experimental colitis by blocking cellular trafficking and protecting intestinal epithelial cells
K Suzuki, Y Kawauchi, SS Palaniyandi, PT Veeraveedu, M Fujii, ...
Pathology international 57 (7), 413-420, 2007
502007
Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure
PT Veeraveedu, K Watanabe, M Ma, SS Palaniyandi, K Yamaguchi, ...
Biochemical pharmacology 75 (6), 1322-1330, 2008
492008
Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy
JCB Ferreira, T Koyanagi, SS Palaniyandi, G Fajardo, EN Churchill, ...
Journal of molecular and cellular cardiology 51 (6), 980-987, 2011
462011
The senescence accelerated mouse prone 8 (SAMP8): a novel murine model for cardiac aging
V Karuppagounder, S Arumugam, SS Babu, SS Palaniyandi, K Watanabe, ...
Ageing research reviews 35, 291-296, 2017
452017
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20